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Introduction 
Binding of radioactive ligand to the receptor
Separation of bound from free
Measurement of the amount of radioactivity bound
Analysis of the results
Muscarinic receptors are members of the 
large family of G protein-coupled receptors 
(GPCRs). These receptors are widely 
distributed throughout the body and are 
responsible for numerous vital functions in 
both the brain and autonomic nervous system 
(Lefkowitz et al., 1990). Activation of 
muscarinic receptors in the periphery causes 
decrease in heart rate, relaxation of blood 
vessels, constriction in the airways of the 
lung, increase secretions and motility of the 
gastrointestinal tract, and increase secretions 
of lacrimal and sweat glands. In the brain, 
muscarinic receptors participate in many 
important functions such as learning, memory 
and posture control (Lefkowitz et al., 1990). 
FIGURE 1 Steps involved in radioligand-receptor 
binding assay. 
The majority of drugs currently available 
that act on muscarinic receptors have limited 
therapeutic utility due to side effects. 
Therefore, the discovery of novel agonists and 
antagonists of muscarinic receptors with fewer 
side effects is desirable.    
Receptor-radioligand binding assays are 
often employed as preliminary screening 
techniques in pharmaceutical discovery 
programmes and are valuable basic research 
tools with wide application in many 
disciplines (Gattu et al., 1995). The basic 
stages involved in the radioligand-receptor 
binding assay are summarized in Figure 1. 
We had developed a 96-well filtration 
based muscarinic radioligand-receptor binding 
assay suitable for medium throughput 
screening. This method allowed rapid 
screening and identification of potential new 
muscarinic agonists and antagonists from 
natural resources.  
 
Materials and Methods 
 
Tissue preparation 
Total brain membrane (minus cerebellum) of 
male Sprague-Dawley rats was prepared 
according to the protocol described by Gattu 
et al. (1995) with minor modifications. Male 
Sprague-Dawley rats (250-300 g) were 
decapitated and the brains removed. The 
cerebellum was dissected out and the rest of 
the brain finely chopped with scissors, 
homogenized in 10 volumes of ice cold 50 
mM Tris-HCl, pH 7.4 buffer using Ultra-
Turax (2 x 10 seconds) and followed by glass-
teflon pestle homogenisation at 800 rpm for 
20 strokes. 
The homogenate was centrifuged at 
40,000 g using ultra high speed centrifuge 
(Ultra Pro 80, Sorvall, USA), type T-880 
rotor at 4°C for 15 min. The pellet was 
retained and washed twice by resuspending in 
ice-cold 50 mM Tris-HCl pH 7.4 buffer 
(centrifuged at 40,000 g, 15 min). The final 
pellet was suspended in 5 mL ice-cold 50 mM 
Tris-HCl pH 7.4 buffer, aliquoted and kept at 
-80°C until use.  
Membrane protein concentration was 
determined by a modified method of Lowry et 
al. (1951) using Sigma Diagnostics Total 
Protein Reagent with BSA as the standard.  
 
Radioligand-receptor binding assay 
All experiments were performed in 
triplicate in a total volume of 250 µl/well. Six 
concentrations of membrane protein (0.06-
2.20 mg/ml) were used to perform tissue 
linearity study and to determine the suitable 
concentration of protein for the saturation and 
competition assay. 
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In saturation and optimisation 
experiments, 200 µl/well membrane 
suspension was added to 0.01-1.0 nM [3H] N-
methyl scopolamine ([3H]NMS) to give total 
binding (TB). Non-specific binding (NSB) 
was determined by adding 25 µl of atropine 
(10-5 M) to the reaction mixture. TB was 
subtracted by NSB to give specific binding 
(SB). The reaction mixture was incubated 
(temperature: 4, 21 and 37ºC; pH: 7.4, 8.0 and 
8.9) for a specified time (0-180 min). After 
incubation, the reaction mixture was filtered 
with GF/C filter plate using a cell harvester 
(FilterMate, PerkinElmer) and washed with 
200 µl/well of buffer (2-10 times). The plate 
was air-dried; bottom seal was then applied 
and followed by addition of 25 µl/well 
scintillation cocktail (MicroScint-O). The top 
side of  the plate was then sealed with 
TopSeal A (PerkinElmer), agitated at 400 rpm 
for 5 min before scintillation counting for 1 
min/well with TopCount NXT (PerkinElmer).
Data analysis 
Data analysis was performed with 
PRISM® Software, version 3.0 (GraphPad, 
USA). Saturation analyses were made by 
nonlinear regression. Ki values were 
calculated according to the equation of Cheng 
and Prusoff (1973).
 
Results  
 
Saturation experiments 
The linearity of [3H]NMS binding as a 
function of increasing amount of protein was 
established for protein concentration up to 
0.67 mg/ml (or 133 µg of protein/well). This 
shows the optimum concentration of 
membrane tissue is 0.11 – 0.20 mg of 
protein/ml (22-40 µg of protein/well). 
The influence of incubation temperature 
and pH (7-9) (Figures 2 and 3) on the 
dissociation constant (KD) and number of 
binding sites present in the membrane 
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FIGURE 2 The effects of temperature on muscarinic radioligand-receptor binding assay. 
TB: Total binding; NSB: Non-specific binding 
FIGURE 3 The effects of pH on muscarinic radioligand receptor binding assays. 
TB: Total binding; NSB: Non-specific binding. 
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receptor (Bmax) was not significant. Rosenthal 
plot (Figure 4) indicates that only one binding 
site existed at the [3H]NMS concentrations 
used to perform the assay.  
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The steady state (equilibrium) for 
muscarinic receptor binding assay was reached 
between 60-180 min after initiation of 
incubation (Figure 5). Hence, 90 min 
incubation was used for further experiments to 
ensure all assays performed have reached the 
steady state before the assay was terminated. 
The optimum number of washings 
required was determined by calculating the 
SB/NSB ratio for each washing performed. 
The ratio of SB/NSB decreased initially, and 
stabilised after 4 times of washing with 
minimal reduction in specific binding 
thereafter. The reason for the decrease is 
probably a result of partial dissociation of the 
bound [3H]NMS from muscarinic receptors. 
Therefore, 4 times of washings was adopted.  
Competition experiments 
Eight drugs which include known 
muscarinic antagonists were prepared in 10 
concentrations (10-3 – 10-12 M) and tested 
using muscarinic receptor binding 
competitive assay. Competitive dose response 
curves for the drugs was shown in Figure 6. 
Ki and IC50 values obtained from the 
competition experiments with known 
muscarinic receptor ligands were 0.30 nM 
(atropine), 0.052 nM (scopolamine) and 1.6 
nM (dicyclomine). Ki for atropine (0.30 nM) 
was 5.6 folds smaller than the reported Ki 
value (1.68 nM) (Gattu et al., 1995). Ki 
obtained for non-muscarinic receptor ligands 
were 5.2 mM (propanolol), 17.2 µM 
(buspirone), 0.98 mM (serotonin), 9.4 µM 
(phentolamine) and 4.1 µM (8-OH-DPAT) 
(Figure 6). 
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FIGURE 5 Incubation time for muscarnic receptor 
binding at pH 7.4, temperature 21 °C. 
 
Bound (fmol/mg)
FIGURE 4 The Rosenthal plot of muscarnic receptor 
binding at pH 7.4, temperature 21 °C. 
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FIGURE 6 Competitive dose response curves for eight drugs. 
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The effects of DMSO 
Due to its physiochemical properties, high 
solvent power, low chemical reactivity, and 
relatively low toxicity, DMSO is a solvent of 
choice for sample storage and handling in the 
pharmaceutical industry, particularly in 
primary high-throughput bioscreening. We 
tested the inhibitory effects of DMSO on the 
muscarinic radioligand-receptor binding assay 
(0.5%-10% v/v at final concentration). The 
results show the inhibition was minimal and 
insignificantly different compared to the 
control, up to 8% v/v DMSO. However at 
10% v/v DMSO, the inhibition was about 
20%. (Figure 7). 
Intra-plate and inter-plate validation 
To assess the quality of assay, we have 
adopted statistical analysis using Z’-factor as 
it is accepted as a more reliable characteristic 
parameter compared to signal/background 
ratio (Zhang et al., 1999). The calculated Z’ 
factor is 0.8 (>0.5) for intra-plate. Coefficient 
variations (CV) for the inter- and intra-plate 
are 4.9% and 5.6% respectively. 
 
Discussion 
In summary, the optimised protocol 
consisted of 36 µg of protein/well, 0.5 nM 
[3H] N-methylscopolamine ([3H]NMS) and 50 
mM Tris-HCl buffer, pH 7.4. The receptor-
radioligand equilibration was reached after 90 
min incubation at 21ºC.  
In this protocol, less than 3 ml of 
scintillation cocktail is needed for 96 wells as 
compared to 4 ml/filter in traditional assays 
(total of 384 ml for 96 wells). This gives a 160 
folds reduction of radioactive waste and hence 
cost saving and reduction in potential hazards.  
Saturation analysis of [3H]NMS gave Bmax 
of 293 fmol/mg protein and KD of 0.059 nM. 
The Bmax value shows the muscarinic receptor 
density is high whilst KD value suggests 
[3H]NMS has high affinity and selectivity 
towards the receptor and is a suitable 
radioligand source. The linear Rosenthal plot 
suggests single site binding in this receptor-
radioligand interaction. The Ki values, low 
intra-, inter-plate variability (CV, 4.9% and 
5.6% respectively) and Z’ factor of 0.8 clearly 
show this assay protocol is robust and reliable 
as a medium throughput screening assay for 
the detection of potential muscarinic receptor 
active compounds in chemical or natural 
products libraries.  
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